We learned at the May 30 webcast that the preclinical study in Glioblastoma had started, which means that it's been approximately 6 months since then. I would think that the study may have completed.

The annual report indicates that "Upon completion of the study, the academic institutions will provide the Company with a research report outlining the study results, and they will have the right to publish and present the study results."

I look forward to hearing more.